Using Acceptance and Commitment Therapy to Improve Outcomes in Functional Movement Disorders: A Case Study by Graham, CD et al.
This is an author produced version of Using Acceptance and Commitment Therapy to 
Improve Outcomes in Functional Movement Disorders: A Case Study.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/114594/
Article:
Graham, CD, Stuart, SR, O’Hara, DJ et al. (1 more author) (2017) Using Acceptance and 
Commitment Therapy to Improve Outcomes in Functional Movement Disorders: A Case 
Study. Clinical Case Studies, 16 (5). pp. 401-416. ISSN 1534-6501 
https://doi.org/10.1177/1534650117706544
© The Author(s) 2017. This is an author produced version of a paper published in Clinical 
Case Studies. Uploaded in accordance with the publisher's self-archiving policy.
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
Running head: ACT IN THE CONTEXT OF FMD 
Using Acceptance and Commitment Therapy (ACT) to improve outcomes 
in functional movement disorders: A case study. 
 
Christopher D. Graham*1,2, Simon R. Stuart3, Daniel J. 2¶+DUD2, Steven Kemp2 
 
 
1Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9LJ. 
2Department of Clinical Neuropsychology, Leeds Teaching Hospitals NHS Trust, St. James 
University Hospital, Leeds, UK, LS9 7TF. 
3Psychological Therapies, NHS Lanarkshire, 40 Chapel Street, Carluke, ML8 4BA. 
 
 
 
 
Published in: Clinical Case Studies, 2017 
 
 
 
Acknowledgements: For fruitful discussion regarding the treatment of FMD, the authors wish 
to acknowledge the staff of the Department of Clinical Neuropsychology and the Department 
of Neurology at Leeds Teaching Hospitals NHS Trust. 
 
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest 
with respect to the research, authorship, and/or publication of this article 
 
Funding: This was unfunded.    
  
*Requests for reprints should be addressed to Dr Christopher D. Graham, Leeds Institute of 
Health Sciences, University of Leeds, Leeds, UK, LS2 9LJ. E-mail: c.d.graham@leeds.ac.uk 
 
Word count main submission: 5311 
Word count abstract: 189 words 
 
ACT IN THE CONTEXT OF FMD 
Author Biographies 
 
Christopher D. Graham is a clinical psychologist and research fellow in behavioural 
medicine at the University of Leeds, UK. He maintains a NHS functional neurological 
disorders clinic. He researches the mechanisms and treatment of functional neurological 
disorders, and ACT/clinical RFT within the context of chronic disease.  
 
Simon R. Stuart is a clinical psychologist with NHS Lanarkshire, Scotland. As part of his 
routine practice in adult mental health, he works with people experiencing functional 
neurological disorders. He has clinical and research interests in the applicability of process-
focused, ACT/RFT approaches both in health settings and in wider social contexts. 
 
Daniel J. 2¶+DUD is a clinical psychologist based at St James's University Hospital, Leeds 
with primary clinical and research interests in brain tumours and the neuropsychological 
impact of neurosurgery.  He also has extensive experience of working with people presenting 
with functional neurological disorders. 
 
Steven Kemp is a consultant clinical nHXURSV\FKRORJLVWDW6W-DPHV¶V8QLYHUVLW\+RVSLWDO, 
Leeds and visiting lecturer at the University of Leeds. His clinical and research interests 
cover the neuropsychology of epilepsy, memory, traumatic brain injury and functional 
neurological disorders. 
 
 
 
 
 
 
 
 
 
 
 
 
ACT IN THE CONTEXT OF FMD 
Abstract 
Although there are many theories of Functional Movement Disorders (FMD), the causes and 
prognosis remain unclear, and there are no treatments with high-quality empirical support. 
Acceptance and Commitment Therapy (ACT) is an acceptance-based behaviour therapy 
which, via altering a process called psychological flexibility, aims to support behaviours that 
are consistent with a SHUVRQ¶Voverarching values ± even in difficult, uncertain or immutable 
contexts. It may therefore have pragmatic benefits in the context of FMD. We outline the 
theoretical basis for ACT and detail a case study of a brief (6 session) intervention for 
increasing personally meaningful activity with FMD. The participant was in her early 
twenties and had been diagnosed with functional propriospinal myoclonus. ACT techniques 
including relational framing, defusion and mindfulness exercises were used to increase 
psychological flexibility, with the goal of enabling effective functioning within the difficult 
context created by FMD. Following treatment, the participant showed a reliable 
change/clinical recovery in psychological flexibility (AAQ-II), FMD symptom interference 
(WSAS; primary outcome) and mood (CORE-10; secondary outcome). This case study 
demonstrates an approach that focuses first on improving functioning with FMD, as opposed 
to eliminating or controlling symptoms.  
 
Keywords: acceptance and commitment therapy; cognitive behavioural therapy; 
relational frame theory; mindfulness; functional neurological disorders; functional movement 
disorders; functional propriospinal myoclonus; neurology; medically unexplained symptoms; 
conversion disorders.  
 
 
 
 
 
 
 
 
 
 
 
ACT IN THE CONTEXT OF FMD 
Using Acceptance and Commitment Therapy (ACT) to improve outcomes in Functional 
Movement Disorders: A case study. 
 
1 Theoretical and Research Basis for Treatment 
People with functional neurological disorders experience neurological symptoms, such as 
seizures, limb weakness, and visual disturbance, which are inconsistent with known disease 
pathologies but are not feigned (van der Hoeven et al., 2015). Functional movement disorders 
(FMD) are a subset of functional neurological disorders that involve motor symptoms, such 
as tremor, dystonia, and limb weakness. FMD are not diagnosed on exclusion alone but also 
on the presence of positive signs, such as tremor entrainment or +RRYHU¶VVLJQ (Stone, 2009). 
They are common presentations to neurology services, accounting for between 5% and 10% 
of movement disorder referrals (Stone, 2009), and are more common in women and younger 
adults (Ellenstein, Kranick, & Hallett, 2011). Outcome is often poor, with approximately 
40% experiencing symptoms five years post-diagnosis (Gelauff, Stone, Edwards, & Carson, 
2014). FMD often cause high levels of functional impairment; consequently, quality of life 
and mood are often affected (Vroegop, Dijkgraaf, & Vermeulen, 2013) and associated 
healthcare costs can be high (Gallagher et al., 2013). 
Understanding and treating FMD  
FMD have been termed µthe crisis for neurology¶ (Hallett, 2006). It is easy to see why: there 
is much debate over aetiology (Edwards, Stone, & Lang, 2014; Wilshire & Ward, 2016); 
there are no treatments with proven efficacy (Ricciardi & Edwards, 2014); and health 
professionals often feel ill-equipped to manage FMD (Yon, Nettleton, Walters, Lamahewa, & 
Buszewicz, 2015).  
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The language used to describe such conditions requires careful consideration. The term 
µpsychogenic movement disorders¶ is used by some clinicians. However, many others find 
this problematic as it can lead to dualistic assumptions that symptoms are µof the mind¶ as 
opposed to being µreal¶; that FMD indicate the presence of mental ill health; and that 
symptoms are XQGHUWKHSDWLHQW¶Vvolition. These assumptions may be in contrast to patients¶ 
experiences and the apparent heterogeneity in presentation (Edwards et al., 2014; Wilshire & 
Ward, 2016). Therefore, the more descriptive term FMD may be preferable (Ding & Kanaan, 
2016). 
There are many theoretical explanations for functional neurological disorders. In the 19th 
century, Jean-Martin Charcot proposed that µhysteria¶ emerged from µfunctional lesions¶ to 
the nervous system (Bogousslavsky, 2011; Ellenstein et al., 2011). This was followed by 
psychodynamic µFRQYHUVLRQ¶ explanations, which are often ascribed to Freud (Spitzer, 
Spelsberg, Grabe, Mundt, & Freyberger, 1999). Wilshire & Ward (2016) summarise these 
prominent early theories as follows: FMD result from the suppression of trauma or emotion-
laden µconflicts¶ creating subconscious psychological tension which is converted into bodily 
symptoms. Symptoms may then be reinforced by secondary gains, e.g. attention from others. 
There is empirical evidence supporting aspects of these theories (Blakemore, Sinanaj, Galli, 
Aybek, & Vuilleumier, 2016; Spitzer et al., 1999). However, a proportion of people with 
FMD report neither antecedent trauma (Stone & Edwards, 2011), nor problems indicative of 
µconflict¶ (van der Hoeven et al., 2015). Further, it is hard to establish whether distress is a 
cause or consequence of FMD. Such conversion explanations therefore appear to have 
limited application across all FMD presentations. 
Cognitive behavioural models of medically unexplained symptoms have broadened the 
number of theoretically implicated processes (Deary, Chalder, & Sharpe, 2007). Arguably the 
unique prediction amongst these is that maladaptive or distorted illness beliefs (e.g. that 
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something is catastrophically physically wrong) inform aberrant illness behaviours (e.g. 
avoidance, seeking medical tests) which, in turn, maintain symptoms. Ostensibly in support, 
people with FMD tend to hold illness perceptions comprising a low level of personal control 
over symptoms, a poor understanding of their symptoms, and a tendency to reject 
psychological causation (Ludwig, Whitehead, Sharpe, Reuber, & Stone, 2015). However, 
perhaps limiting the explanatory and/or clinical value of this aspect of the model, one might 
contend WRZKDWH[WHQWSHRSOH¶VEHOLHIVDUHGLVWRUWHG; instead, they appear appropriate to 
reflect the context of living with FMD.  
A recent predictive coding account of FMD (Edwards, Adams, Brown, Pareés, & Friston, 
2012) details a process whereby FMD can result from disturbances in basic neurocognitive 
processes of which a person is unlikely to be aware: sensory feedback during movement and 
attention to movement. These processes can become represented in higher-level cognitive 
processing, such as illness beliefs, and vice-versa. This model is supported by empirical 
evidence of sensorimotor and attentional disturbances in FMD (Macerollo et al., 2015; van 
Poppelen et al., 2011). The salient advance in this newer model is that it emphasises that 
treatments might be effective without necessarily having a mental health/psychoeducation 
focus. Thus, neuro-rehabilitation treatments such as physiotherapy might also be viable.  
Treatment   
A recent narrative review of FMD treatment studies concluded that several treatments 
showed promising application, but noted a dearth of high-quality evidence supporting any 
particular approach (Ricciardi & Edwards, 2014). A small trial of neuroleptics showed post-
intervention symptom reduction, but with unwanted side effects (Rampello et al., 1996). An 
uncontrolled study of antidepressants returned broadly positive results (Voon & Lang, 2005). 
Mirroring the popularity of conversion theories, in the largest psychotherapy study, 15 people 
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with FMD were randomised to immediate or delayed psychodynamic treatment. This aimed 
to directly alter symptoms by ³«making unconscious phenomena conscious and working 
through underlying conflicts.´(Kompoliti, Wilson, Stebbins, Bernard, & Hinson, 2014), p. 
61). Although likely underpowered, no significant improvement in symptoms or mood could 
be attributed to the intervention. A traditional cognitive behavioural therapy (CBT) case 
study was also identified. In line with the cognitive behavioural model (Deary et al., 2007), 
this aimed to improve FMD symptoms directly by targeting ³«DXWRPDWLFWKRXJKWV«and 
somatic misinterpretations«´(LaFrance & Friedman, 2009). Outcome measures are unclear, 
though the authors¶ subjective report is that symptoms had desisted. Similarly, a case study of 
an integrative psychotherapy approach to functional neurological disorders, including FMD, 
observed a post-intervention improvement in symptoms, but without objective measurement 
(Baslet & Hill, 2011). In line with newer conceptualisations of FMD (Edwards et al., 2012), 
there is increasing interest in physiotherapy (Nielsen et al., 2014). A small RCT (N = 57) 
demonstrated post-intervention improvements in symptom severity and aspects of quality of 
life in the FMD sub-group without psychiatric co-morbidity (Nielsen et al., 2016). 
Acceptance and Commitment Therapy (ACT) 
For a number of theoretical and pragmatic reasons, we propose that a newer type of 
acceptance-based behaviour therapy, called Acceptance and Commitment Therapy (ACT), 
may have utility in FMD. ACT is an acceptance-based behaviour therapy that has a strong 
evidence base for improving outcomes in chronic pain (Hann & McCracken, 2014), and a 
growing evidence base for improving functioning with mental health conditions (A-Tjak et 
al., 2015) and chronic diseases (Graham, Gouick, Krahé, & Gillanders, 2016), including 
neurological conditions (Carrigan & Dysch, 2015; Graham, Gillanders, Stuart, & Gouick, 
2015). 
ACT IN THE CONTEXT OF FMD 
Underlying theory and psychological flexibility 
ACT has its roots in radical behaviourism, and is informed by Relational Frame Theory 
(RFT). RFT posits that a fundamental human behaviour is verbally µrelating¶: i.e. deriving 
relationships between such stimuli as words, objects and emotions, thereby creating complex 
symbolic networks. Relating behaviour is reinforced by its utility for rapid acquisition of 
information and in predicting outcomes; however, it also brings with it negative implications. 
For example, we will often engage in behaviours that are in line with prior learning (symbolic 
constructions), rather than engaging in behaviours more directly in line with the current 
situation or indeed with our own personal values (McCracken, 2011).  
These theoretical underpinnings shape ACT in several ways. For example, they suggest that 
the elimination or control of thoughts and feelings may be an ineffective long-term treatment 
goal, because control and suppression behaviours may become pathologically related to the 
experience being controlled (for example a thought, emotion or bodily sensation; Hayes, 
2004). Another implication is that making the uncovering of objective truths a treatment goal 
can become counter-productive, mirroring rumination and worry in function, and causing 
insensitivity to other important aspects of experience (Villatte, Hayes, & Villatte, 2015). 
Therefore, instead of focusing treatment on reducing or controlling unwanted thoughts and 
feelings, or trying to align beliefs with essential truths, ACT aims to promote a general 
process called psychological flexibility, which can be defined as consisting of three 
components: ³«the capacity to persist or to change behaviour in a way that 1) includes 
conscious and open contact with thoughts and feelings (openness), 2) appreciates what the 
VLWXDWLRQDIIRUGVDZDUHQHVVDQGVHUYHVRQH¶VJRDOVDQGYDOXHVHQJDJHPHQW´
(McCracken & Morley, 2014, p. 225.)  
Therapy techniques 
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ACT uses a range of methods to engender psychological flexibility. The therapist will explore 
the participant¶s overarching µvalues¶, such as performing as a nurturing parent, or creativity 
in work. Participants are encouraged consciously to initiate actions that support their values, 
for example by spending time with children, disclosing emotions and opinions, etc. (Dahl, 
2015). To assist this committed action, the therapist facilitates development of the openness 
and awareness aspects of psychological flexibility, often using variations of mindfulness 
practice and perspective-taking.  
As the medium for many ACT treatment techniques is language, therapists might therefore be 
creative in using relational framing (i.e. purposefully creating new relationships between 
words, and other stimuli) within the clinical conversation to help create the conditions in 
which new psychologically flexible behaviours might occur (Villatte et al., 2015; see Table 
1). Perhaps the most obvious example of using framing within therapist-client interactions is 
metaphorIRUH[DPSOH³Thoughts and feelings are like the weather´. Here, co-ordination 
framing (see Table 1) is used to associate thoughts and emotions with weather experiences 
(e.g. transience, familiarity and inevitability). Consequently, participants might begin to 
notice that they can watch thoughts and feelings from a distance, like they do the weather, or 
that emotions can change independently of our own efforts, like the weather. Thus, framing 
can be used to create the conditions for different responses to emotions, thoughts and bodily 
sensations.  
Proposing ACT for improving outcomes in FMD 
Many have argued that ACT offers pragmatic benefits in working with people living in 
unclear, difficult or immutable contexts such as chronic pain and chronic disease (Graham et 
al., 2016; McCracken & Vowles, 2014). It may therefore offer several benefits in the context 
of FMD.  
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i. Fully applicable across FMD presentations and treatment contexts 
The focus of ACT enables this model to function well within the uncertain context created by 
FMD and across a heterogeneous patient group. Rather than seeking directly to control or 
eliminate FMD symptoms, related cognitions or emotions, the primary ACT treatment goal is 
to help orient the person towards activity they find meaningful, given the difficulties caused 
by FMD (or indeed other sources of psychological pain). Consequently, FMD can be as a 
participant experiences/perceives them, and this need not change for therapy to be effective. 
For example, where a person with FMD experiences disabling symptoms, with no control 
over symptoms, then negative automatic thoughts, illness beliefs, and unwanted emotions 
might simply reflect this context. As we have advanced for chronic diseases, ACT¶s focus on 
finding ways to enact personally meaningful activity, while developing openness to difficult 
thoughts and feelings, might offer more scope for change than attempts directly to change 
beliefs about illness, the self or the future, or to control distress (Graham et al., 2016). 
Similarly, if a person brings a workable conceptualisation that FMD is affected by a mental 
health problem or is an emotional response, ACT is also applicable, showing promise for 
improving outcomes in mental health conditions (A-Tjak et al., 2015). As is effectively done 
in chronic pain contexts, an ACT perspective might also be used to enhance physiotherapy 
and multi-disciplinary treatments for FMD (Jacobs, Guildford, Travers, Davies, & 
McCracken, 2016; Vowles & McCracken, 2008).  
ii. A different approach to symptom-focused attention  
FMD can involve aberrant symptom-focused attention (Edwards et al., 2012; Macerollo et al., 
2015), with diagnosis informed by the distractibility of symptoms (Stone, 2009). Thus, 
treatments which alter symptom-focused attention might have value. However, attempts to do 
this may be counter-productive if change in attentional processes (or indeed symptom 
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control) is an explicit treatment goal. The salience of symptoms and associated experiences 
may paradoxically increase via vigilance (i.e. to initiate or maintain distraction) and outcome 
monitoring (i.e. evaluating the success or failure of control attempts). Such a focus also risks 
increased FMD symptom interference, because control of symptom experiences may come at 
the cost of personally meaningful activity. In contrast, for the purpose of increasing such 
activity ± and not controlling symptom experiences ± ACT incorporates aspects of 
mindfulness: learning to allow present experiences, even those which are undesired, to occur 
without elaboration (Lindsay & Creswell, 2017). This may change the quality of self-focused 
attention from threat monitoring to acceptance and thus reduce symptom interference  
(Wilson, Barnes-Holmes, & Barnes-Holmes, 2014). 
2 Case Introduction  
Claire (not her real name) was in her early twenties. Twelve months prior to her referral she 
had received a diagnosis of functional propriospinal myoclonus, an FMD which involves 
recurrent pelvic spasms (van der Salm et al., 2014). Following a later acute hospital 
presentation for functional limb weakness, she was referred by her neurologist to a clinical 
neuropsychology outpatient service for treatment of FMD, and was treated by a clinical 
psychologist.  
3 Presenting complaints 
Claire reported that her myoclonic jerks occurred consistently throughout the day. She stated 
that these were interfering with her functioning and causing her distress; however, she was 
able to maintain employment. She also reported significant low mood, which affected her 
well-being via rumination and sleep dysfunction (short and disturbed sleep). Although she 
noted that her mood was affected by FMD, she was uncertain whether her mood was a causal 
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or maintaining factor for her symptoms.  Her initial treatment goals were to gain control over 
her spasms, and to improve her mood. 
4 History 
Claire had a normal neurodevelopmental history, and had performed well at school. She had a 
history of low mood, beginning several years prior to the onset of FMD. She was prescribed 
antidepressant medication for low mood, and had been taking this medication prior to the 
onset of FMD.  
Aside from this, she was in good health. She had recently returned to her country of birth 
after several years living abroad. She described her time abroad as particularly stressful, 
involving several difficult relationships, and a limited support system. Her spasms became 
apparent while abroad, and resulted in a referral to neurology, where she received a diagnosis 
of FMD. Upon relocation, her FMD continued and her sleep and mood became more 
problematic. Nonetheless, she was able to find employment, and maintain a social life, albeit 
slightly limited.  
Nine months following her diagnosis, she experienced an acute worsening of her spasms 
alongside functional limb weakness. She was unable to identify a specific precipitant to this 
acute worsening in her symptoms. This led to an emergency presentation to a neurology 
clinic. Consequently, she was briefly hospitalised and treated with benzodiazepines. These 
dampened symptoms slightly but caused side-effects and so were abandoned. At this point, 
she was referred to clinical neuropsychology. 
5 Assessment 
Assessment included a clinical interview alongside validated questionnaire measures of 
outcome and process variables. To our knowledge, there are no measures which have been 
psychometrically validated for use in FMD. We thus chose widely used, clinically relevant 
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measures. This was a pragmatic case study, undertaken within routine UK National Health 
Service clinical work. Therefore, the assessment of changes in outcome measures over the 
period of the intervention was undertaken within a simple pre- and post-intervention design. 
Clinical interview 
This involved a standard clinical interview, comprising discussion of family background, co-
morbid health conditions, development, social and occupational functioning, mood, etc. 
&ODLUH¶Vunderstanding of FMD was elicited, and then, in more detail, the consequences of 
FMD, particularly functioning and emotional repercussions. Questionnaires were used both to 
support such enquiry, and as outcome measures (below). Based on the information given by 
her neurologists, &ODLUH¶Vunderstanding was that her condition was the result of problems 
with brain signals reaching parts of her body. Although it had been previously been suggested 
to her that stress might be a cause (by a neurologist), she was uncertain about this. In line 
with ACT, psychological flexibility was assessed via interview, and with a questionnaire 
(below).  
Acceptance and Action Questionnaire II (AAQ-II)  
The AAQ-II (Bond et al., 2011) is a widely used measure of psychological flexibility. An 
example item is µWorries get in the way of my success¶. The rating scale ranges from 1 
(never true) to 7 (always true) and total scores range from 7 to 49, with higher scores 
indicating lower psychological flexibility. &ODLUH¶V pre-treatment AAQ-II scores indicated 
quite low psychological flexibility (31/49), similar to a sample seeking outpatient counselling 
(M = 28.34, SD = 9.92; Bond et al., 2011). 
Work and Social Adjustment Scale (WSAS) 
The WSAS (Mundt, Marks, Shear, & Greist, 2002) is brief measure of symptom interference 
with functioning ascribed to a specific condition (here FMD). An example item is µBecause 
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of my FMD my social leisure activities (e.g. parties, bars, outings, visits, dating etc.) are 
impaired¶. Responses are made on a scale from 0 (not at all impaired) to 8 (severely 
impaired) and scores range from 0 to 40, with higher scores indicating greater symptom 
interference. Claire demonstrated a seemingly moderate impact of FMD on functioning 
(16/40), at the lower end of a range of scores obtained from a sample of people with FMD 
entered into a previous RCT of physiotherapy (M = 24.7, SD = 7.9; Nielsen et al., 2016). The 
WSAS was used as our primary outcome measure because it captures interference with 
personally meaningful behaviours. Therefore, arguably, the WSAS is a more ACT-consistent 
primary outcome measure than a general quality of life scale.   
CORE-10 
The CORE-10 is a brief measure of mood and distress (Barkham et al., 2013), which is often 
used in primary care and clinical health psychology settings in the UK. Scores range from 0 
to 40, with higher scores indicating greater mood disturbance. It has clinical cut-offs of <11 
for general psychological distress and <13 for depression. At presentation, &ODLUH¶VPRRGZDV 
above both cut-offs (21/40), indicating psychological distress to the extent which indicated 
the likely presence of depression. 
6 Case conceptualisation 
The clinical interview supported the low psychological flexibility scores on the AAQ-II. 
Thus, we undertook a person-centred formulation of how lower psychological flexibility 
might increase the impact of FMD-related symptom experiences, resultant emotions and 
other sources of psychological distress on personally meaningful functioning. 
Engagement 
Claire was unclear about her values, which are defined in ACT as freely chosen qualities of 
ongoing action or direction that serve as intrinsically reinforcing means to co-ordinate future 
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behaviour (Dahl, 2015). This lack of values clarity appeared to impact on her behaviour in 
several ways. First, because her choices (for example, where to live, career, etc.), were not 
consciously anchored in her values, they had a quality of spontaneity and were often 
influenced by the presence of strong emotions. For example, she had decided to move to 
another country, but had not consciously considered her goals beyond relocating. A lack of 
connection between her choices and her values may also have contributed to a reduced 
momentum in her behaviours, because she was missing the intrinsic positive reinforcement 
which can occur when we meet our goals (Dahl, 2015). Nonetheless, at presentation she was 
active in employment and was able to keep her commitments. Thus, once selected, there was 
consistency in her behaviours, and she was quite active given the presence of FMD. We 
therefore hypothesised that she was able and willing to make changes to support her values, 
EXWZDVQ¶WVXUHZKLFKWRHQDFW.  
Openness and awareness 
We then considered the openness and awareness aspects of psychological flexibility. At 
presentation, Claire was using several apparently ineffective methods to manage emotions 
and thoughts related to her stressful time abroad and to FMD. Distraction was being used 
during the day in an attempt to avoid or diminish unwanted thoughts and emotions; at night, 
it seemed that rumination served the function of trying to uncover essential truths about her 
time abroad, with the goal of being relieved of associated discomfort and uncertainty. Both 
strategies seemed to serve the function of experiential avoidance: behavioural attempts to 
avoid unwanted private events. However, such attempts can paradoxically increase the 
interference of emotions and thoughts (Hayes, 2004). There is evidence of an ironic increase 
in the frequency and intensity of supressed thoughts longer-term (Clark, Ball, & Pape, 1991), 
while relational framing can extend this beyond the initial stimuli being supressed (Hooper, 
Saunders, & McHugh, 2010). Perhaps via such a mechanism, &ODLUH¶Vsleep was becoming 
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increasingly affected, and she reported feeling increasingly upset, guilty and ashamed that 
neither mood nor FMD were improving, despite her best efforts. The consistent use of 
ineffective emotion-regulation methods also suggested difficulties tracking the antecedents 
and consequences of some of her behaviours. We thus hypothesised that, alongside 
experiential avoidance, symptom interference was being aggravated by an insensitivity to 
context (i.e. a difficulty noticing the consequences and antecedents to some of her 
behaviours), and by a limited behaviour repertoire in the presence of aversive stimuli.  
In summary, at presentation Claire was managing to function to a reasonable extent given the 
presence of FMD. However, interactions between the use of logical yet ineffective strategies, 
combined with unclear longer-term goals and values, appeared to be increasing FMD 
symptom interference (particularly via poor sleep and increased emotional impact) and 
affecting mood. 
 
7 Course of Treatment and Assessment of Progress 
Content of the intervention 
FMD was first explained as being the result of changes in brain functioning, with a 
proportion of people recovering entirely over time. Claire was receptive of this explanation.  
Treatment was introduced as a means to increase personally meaningful activity, with FMD. 
This partially served the purpose of having attention on meaningful activity as opposed to 
symptom control. In line with her initial treatment goals, changes in symptoms and mood 
were acknowledged as events that could possibly occur during the course of treatment.  
Several methods were used to increase psychological flexibility, in order to enable Claire to 
function as well as possible with FMD. In treatment we moved flexibly around the 
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components detailed below, and Table 1 further explicates the relational framing techniques 
and metaphors that were used.  
Engagement 
To increase engagement, the therapist led discussion of her values. This involved the use of 
various framing methods, for example: ³When you feel most alive, what are you doing, or not 
GRLQJ"´This is an example of comparative framing (as in Table 1). Claire described values 
involving experiencing nature, connecting with family, and spirituality. She later generated 
and experimented with new behaviours that might enable progress on her values (e.g. 
mindfulness practice, trips to local parks). She also maintained some existing behaviours such 
as going running, now more conscious of their role in helping her make progress towards her 
values.   
Openness and awareness 
To improve her ability to notice the antecedents, consequences and effectiveness of her 
behaviours (context sensitivity), &ODLUH¶Vattention was directed to their outcomes and 
functions, oftHQIUDPHGLQUHODWLRQWRYDOXHV³Did this/might this take you in the direction 
\RXZDQWWRJRLQ"´ This mostly applied to the strategies enacted in response to aversive 
emotions (e.g. rumination and distraction), but was also encouraged to track the progress of 
newly acquired behaviours. To support this, mindfulness practice was introduced as a way to 
enhance further the intrinsic positive reinforcement of some behaviours consistent with her 
values (e.g. running, exploring nature). 
To reduce the influence of unwanted emotions over personally meaningful activity, several 
methods were used to foster experiential acceptance. This began with Claire describing 
thoughts and feelings related to her stressful time abroad. The therapist purposefully 
encouraged her to slow down and attend more deliberately to these experiences (the thoughts, 
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emotions and bodily sensations present). Through this process Claire noticed that she could 
be in the presence of difficult thoughts and feelings, without necessarily needing to enact 
behaviours to diminish these experiences.  
From here, metaphor ± mostly an adapted and extended version of the bus metaphor (Hayes, 
Strosahl, & Wilson, 1999) ± was used to change her relationship with (transform the stimulus 
functions of) clinically relevant emotions, thoughts and feelings, and to reduce their impact 
over goal-directed behaviours. The aim here was to help Claire to notice that she could 
choose to open up to difficult thoughts and feelings, and still act effectively ± i.e. 
commensurate with her values ± in their presence. First, within this bus metaphor, unwanted 
thoughts and feelings were personified as passengers on a bus, which Claire was attempting 
to drive in the direction of her values. Situated against her real experiences (relationships, 
symptoms, etc.), Claire noticed that when she drove in the direction of her values ± i.e. 
attempted to undertake behaviours consistent with her values ± her passengers (unpleasant 
memories, self-evaluative thoughts, anxiety) would often interrupt her, and she would then 
take a detour (stop doing what was important to her, losing track of her values). Framing 
(hierarchical and co-ordination) enabled an association between aversive emotions, thoughts 
and bodily sensations ± passengers ± and her direction of travel, her values. Through such 
metaphor, aversive experiences could be reframed as part of positive behaviours, thereby 
adding appetitive aspects to stimuli that were previously experienced as aversive. This also 
appeared to increase &ODLUH¶Vwillingness to be with painful stimuli when doing so served her 
values. She also noticed that she could hold, and travel with, unwanted thoughts and feelings; 
that they were a part of her experience but not all of her experience (hierarchical framing). 
The use of this and other metaphors (Table 1) also served the purpose of helping Claire to 
experience her verbal thought content from a different, less literal perspective (Foody et al., 
2014).   
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Finally, in working with guilt and shame, and to encourage a more flexible experience of the 
self, we used temporal and deictic framing, for example: ³If an older you ± you in your 
seventies ± walked into this room, what would she see? What would she say about your 
VLWXDWLRQ"´ This appeared to allow Claire to notice her present thoughts and feelings from a 
broader perspective, including their relationship to situations that had given rise to them. The 
result appeared to be improved sensitivity to context which led to increased self-compassion. 
In other words, from another perspective ± an older, wiser her ± she could see her present self 
and struggles as influenced by the difficult context in which she found herself (i.e. living with 
FMD, following her difficult time abroad). Thus, following a shift in perspective, unnoticed 
aspects of context became apparent as influences on her thoughts, feelings and behaviour.  
Where appropriate, the therapist used honest, albeit limited, self-disclosure where it might 
enhance psychological flexibility and reinforce the therapeutic relationship. Frames of co-
ordination (e.g. ³all of us´; ³I also´EHWZHHQtherapist and participant were used to derive 
functions of commonality and normality. Arguably, all of us try to get rid of difficult 
thoughts and feelings, can struggle in the face of their difficult contexts, and have learning 
histories often at odds with our current situations.  
Results and Progress 
Over the course of the intervention, Claire was increasingly able to identify values and to 
enact a range of behaviours supporting these ± with FMD present. She began to approach 
unwanted thoughts and feelings differently: she showed greater willingness to experience 
them, could view them outside of pre-intervention language systems (i.e. as metaphors), and 
was less inclined to distract herself when such phenomena were present. Thus, time spent 
struggling with unwanted thoughts and feelings reduced, and time spent engaged in 
personally meaningful activity increased.  
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To quantify the extent of changes in outcome measures (WSAS, CORE-10, AAQ-II) we 
calculated the Reliable Change Index (RCI) and Clinically Significant Change (CSC) (Table 
2). These analyses use normative and psychometric data to calculate a) whether or not change 
is likely to be explained by measurement error (reliable change), and b) whether change is to 
the extent that it indicates clinical recovery (clinically significant change) (Jacobson & Truax, 
1991; Morley & Dowzer, 2014). For Claire, a large change in all outcomes was apparent, to 
the extent that it indicated reliable change and clinical recovery in symptom interference, 
mood and psychological flexibility (Table 2). In addition to these improvements in targeted 
processes, Claire volunteered that her µspasms¶ (i.e. functional propriospinal myoclonus) had 
almost entirely stopped by the end of treatment. 
8 Complicating Factors 
Although Claire had a fast and positive response to treatment, this was a very brief 
intervention ± just six sessions, inclusive of assessment. Given that many of her less 
psychologically flexible behaviours had been established over many years, Claire may have 
benefited from follow-up sessions to help reinforce her new behaviours. She also experienced 
a difficult interpersonal problem halfway through treatment, between sessions 3 and 4. In 
session 4, Claire verbally reported an acute subjective worsening of mood. This impacted on 
her sleep, and her level of physical activity reduced for several days. However, this was 
viewed not as a setback but as another opportunity to contextualise difficult thoughts and 
feelings, to increase context sensitivity, and to practise psychologically flexible behaviours in 
a new difficult context.  
9 Access and Barriers to Care  
There were no financial or access barriers to care. Treatment was provided by the National 
Health Service (United Kingdom), which offers publicly funded medical care. However, due 
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to a number of factors (e.g. service parameters, relocation) a brief intervention was agreed at 
the beginning of treatment.  
10 Follow-up 
Due to relocation, we were unable to complete a follow-up assessment with validated 
questionnaires. However, in an ad-hoc e-mail received four to six weeks after the end of 
treatment, Claire reported that symptom interference related to FMD remained minimal. 
Nevertheless, she also stated that she had noticed some instances of acute anxiety. Our 
tentative explanation is that this may have been a response to a change in context (i.e. 
relocation). Thus, a limitation of the case study is that we were unable to confirm the 
maintenance of improvements in outcome and process variables.   
11 Treatment Implications of the Case 
We advanced that ACT may be applicable to improving outcomes in FMD, mostly for similar 
reasons as have been advanced in chronic pain (McCracken & Morley, 2014) and chronic 
diseases (Graham et al., 2016): these being pragmatic benefits in difficult, uncertain or 
immutable contexts. Although stronger inferences to the intervention could have been made 
if we had used a multiple baseline design, this case demonstrated the successful application 
of a brief ACT intervention for improving functioning with FMD. Post-intervention 
measurement, alongside participant behaviour, showed reduced symptom interference with 
personally meaningful activity, and improved mood. These improvements in outcomes may 
have been mediated by an improvement in psychological flexibility.  
Although this was not the primary treatment focus, a post-intervention improvement in FMD 
symptoms was also described. This may have come about via more frequent meaningful 
activity leading to improved physical condition or confidence. Improvement might also be 
explained via newer models of FMD that implicate the impacts of aberrant symptom-focused 
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attention (Edwards et al., 2012): in short, that a change in the quality of attentional focus on 
movement ameliorated symptoms (possibly even via a placebo effect). Similar symptomatic 
improvement was seen in an earlier case study using a broadly similar approach with a person 
experiencing non-cardiac chest pain following stroke (Graham et al., 2015). However, it is 
also possible that symptom improvement was completely extraneous to the intervention (e.g. 
spontaneous change in an unknown neurological process). 
The case study illustrates some key benefits to adopting ACT in the context of FMD. Here, 
FMD was first approached as we would approach a chronic disease: altering behaviour to live 
as best one can within a challenging context (Graham et al., 2016). Although this case could 
have attracted a psychogenic or conversion explanation, since symptoms first became 
apparent during times of stress, no such assumption was required for the intervention to be 
effective. Further, we were not required to suggest that unrealistic illness beliefs or resulting 
illness behaviours were implicated in the symptoms; thus we did not attempt to change what 
the person believed about their condition. Indeed, because the focus was not on controlling or 
removing it, the FMD was rarely discussed after the assessment, apart from as a context for 
difficult thoughts and feelings, and to disentangle direct limitations of functioning.  
12 Recommendations to Clinicians and Students 
The unique features of ACT may render it particularly useful in the context of FMD. 
Nonetheless, we suggest that many ACT methods ± particularly relational framing ± either 
overlap with, or can be incorporated into, other treatment frameworks, e.g. traditional CBT, 
systemic therapy, psychodynamic therapy or person-centred counselling (Villatte et al., 
2015). For example, in many cases the approach might benefit from shifting focus to 
increasing personally meaningful functioning, as opposed to seeking directly to reduce FMD 
symptom experiences.  
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We would caution that advancing the engagement aspects of psychological flexibility ± i.e. 
values and committed action ± does not involve relentless pushing from therapists. Rather, 
we suggest that actions should be freely chosen to connect with personal values. The 
effectiveness and utility of new behaviours can be placed within WKHSHUVRQ¶Vown experience, 
including the limitations imposed by symptoms. For example, increased awareness may help 
people to notice that relentless pursuit of some behaviours leads to boom±bust patterns of 
fatigue and pain, at which point therapy might focus on helping the person to ascertain 
whether altering or persisting with new behaviours is most workable.  
Also, we expect that if a person is engaging in new behaviours solely or mostly to please the 
therapist, other people or society at large, this might result in short-term benefits at best, since 
any new behaviours will not be sufficiently intrinsically reinforcing. It is important to note 
that an ACT conceptualisation of personally meaningful activity does not necessarily 
comprise increasing physical activity or exertion, as might be a focus in Graded Exercise 
Therapy. Instead, it is about creating a context in which a person can consciously choose to 
enact behaviours supporting their values. Behavioural changes may appear subtle, for 
example calling family members more often, or being more open about difficulties caused by 
FMD. Changes might also comprise nuanced shifts in the quality of already enacted 
behaviours, for example mindfully savouring the processes of work, parenting, socialising or 
romance, as opposed to focusing on outcomes (promotions, FKLOGUHQ¶s exam results, 
marriage, etc.).  
Finally, we are making the testable assumption that, as in other difficult contexts such as 
chronic diseases and chronic pain, having lower psychological flexibility makes it harder to 
live with the challenges imposed by the condition. However, we are categorically not making 
the assumption that low psychological flexibility causes FMD. Thus, the presence of FMD 
does not imply that someone has poor psychological flexibility. The clinical implication is 
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that while many people with FMD may benefit from ACT, some will not require or benefit 
from it. ACT is most likely useful if psychological flexibility is assessed as problematic, and 
if people are keen to increase their functioning as a standalone intervention or as part of a 
multidisciplinary intervention. Although this hypothesis needs to be tested in comprehensive 
trials with larger sample sizes, or by using more detailed N-of-1 analysis, we advance that 
ACT represents a promising psychological intervention for improving outcomes in FMD.  
References 
A-Tjak, J. G.., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A., & Emmelkamp, P. M. (2015). A 
meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant 
mental and physical health problems. Psychotherapy & Psychosomatics, 84(1), 30-36. doi: 
10.1159/000365764 
Barkham, M., Bewick, B., Mullin, T., Gilbody, S., Connell, J., Cahill, J., . . . Evans, C. (2013). The 
CORE-10: A short measure of psychological distress for routine use in the psychological 
therapies. Counselling and Psychotherapy Research, 13(1), 3-13. doi: 
10.1080/14733145.2012.729069 
Baslet, G., & Hill, J. (2011). Case Report: Brief Mindfulness-Based Psychotherapeutic Intervention 
During Inpatient Hospitalization in a Patient With Conversion and Dissociation. Clinical 
Case Studies, 10(2), 95-109. doi: 10.1177/1534650110396359 
Blakemore, R. L., Sinanaj, I., Galli, S., Aybek, S., & Vuilleumier, P. (2016). Aversive stimuli 
exacerbate defensive motor behaviour in motor conversion disorder. Neuropsychologia, 93(Pt 
A), 229-241. doi: 10.1016/j.neuropsychologia.2016.11.005 
Bogousslavsky, J. (2011). Hysteria after Charcot: back to the future. Frontiers in Neurology and 
Neuroscience, 29, 137-161. doi: 10.1159/000321783 
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., . . . Zettle, R. D. 
(2011). Preliminary psychometric properties of the Acceptance and Action Questionnaire±II: 
A revised measure of psychological inflexibility and experiential avoidance. Behavior 
therapy, 42(4), 676-688.  
Carrigan, N., & Dysch, L. (2015). Acceptance and Commitment Therapy for the Management of 
Chronic Neuropathic Pain in Multiple Sclerosis: a Case Study. Neuro-Disability and 
Psychotherapy, 3(2), 69-92.  
Clark, D. M., Ball, S., & Pape, D. (1991). An experimental investigation of thought suppression. 
Behaviour Reseaarch Therapy, 29(3), 253-257.  
Connell, J., & Barkham, M. (2007). CORE-10 user manual, version 1.1. CORE System Trust & CORE 
Information Management Systems Ltd, 1-40.  
Dahl, J. (2015). Valuing in ACT. Current Opinion in Psychology, 2, 43-46. doi: 
http://dx.doi.org/10.1016/j.copsyc.2015.03.001 
Deary, V., Chalder, T., & Sharpe, M. (2007). The cognitive behavioural model of medically 
unexplained symptoms: a theoretical and empirical review. Clinical Psychology Review, 
27(7), 781-797. doi: 10.1016/j.cpr.2007.07.002 
Ding, J. M., & Kanaan, R. A. A. (2016). What should we say to patients with unexplained 
neurological symptoms? How explanation affects offence. Journal of Psychosomatic 
Research, 91, 55-60. doi: http://dx.doi.org/10.1016/j.jpsychores.2016.10.012 
Edwards, M. J., Adams, R. A., Brown, H., Pareés, I., & Friston, K. J. (2012). A Bayesian account of 
µK\VWHULD¶Brain, 135(11), 3495-3512. doi: 10.1093/brain/aws129 
ACT IN THE CONTEXT OF FMD 
Edwards, M. J., Stone, J., & Lang, A. E. (2014). Functional/psychogenic movement disorders: Do we 
know what they are? Movement Disorders, 29(13), 1696-1697. doi: 10.1002/mds.26039 
Ellenstein, A., Kranick, S. M., & Hallett, M. (2011). An Update on Psychogenic Movement 
Disorders. Current neurology and neuroscience reports, 11(4), 396-403. doi: 
10.1007/s11910-011-0205-z 
Foody, M., Barnes-Holmes, Y., Barnes-Holmes, D., Törneke, N., Luciano, C., Stewart, I., & 
McEnteggart, C. (2014). RFT for clinical use: The example of metaphor. Journal of 
Contextual Behavioral Science, 3(4), 305-313. doi: 
http://dx.doi.org/10.1016/j.jcbs.2014.08.001 
Gallagher, P., Meldrum, S., Copstick, S., Burnel, A., Matthews, A., Brown, M., . . . Razvi, S. (2013). 
MEDICALLY UNEXPLAINED NEUROLOGICAL SYMPTOMS ON AN ACUTE 
NEUROLOGY WARD: HEALTHCARE RESOURCE UTILISATION. Journal of 
Neurology, Neurosurgery & Psychiatry, 84(11), e2. doi: 10.1136/jnnp-2013-306573.56 
Gelauff, J., Stone, J., Edwards, M., & Carson, A. (2014). The prognosis of functional (psychogenic) 
motor symptoms: a systematic review. Journal of Neurology, Neurosurgery & Psychiatry, 
85(2), 220-226. doi: 10.1136/jnnp-2013-305321 
Graham, C. D., Gillanders, D., Stuart, S., & Gouick, J. (2015). An Acceptance and Commitment 
Therapy (ACT)±Based Intervention for an Adult Experiencing Post-Stroke Anxiety and 
Medically Unexplained Symptoms. Clinical Case Studies, 14(2), 83-97. doi: 
10.1177/1534650114539386 
Graham, C. D., Gouick, J., Krahé, C., & Gillanders, D. (2016). A systematic review of the use of 
Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. 
Clinical Psychology Review, 46, 46-58. doi: http://dx.doi.org/10.1016/j.cpr.2016.04.009 
Hallett, M. (2006). Psychogenic movement disorders: a crisis for neurology. Current Neurology and 
Neurosciences Report, 6(4), 269-271.  
Hann, K. E., & McCracken, L. M. (2014). A systematic review of randomized controlled trials of 
Acceptance and Commitment Therapy for adults with chronic pain: Outcome domains, design 
quality, and efficacy. Journal of Contextual Behavioral Science, 3(4), 217-227.  
Hayes, S. C. (2004). Acceptance and commitment therapy, relational frame theory, and the third wave 
of behavioral and cognitive therapies. Behavior Therapy, 35(4), 639-665.  
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An 
experiential approach to behavior change: Guilford Press. 
Hooper, N., Saunders, J., & McHugh, L. (2010). The derived generalization of thought suppression. 
Learning & Behavior, 38(2), 160-168. doi: 10.3758/lb.38.2.160 
Jacobs, C. M., Guildford, B. J., Travers, W., Davies, M., & McCracken, L. M. (2016). Brief 
psychologically informed physiotherapy training is associated with changes in 
SK\VLRWKHUDSLVWV¶DWWLWXGHVDQGEHOLHIVWRZDUGVZRUNLQJZLWKSHRSOHZLWKFKURQLFSDLQBritish 
Journal of Pain, 10(1), 38-45. doi: 10.1177/2049463715600460 
Jacobson, N. S., & Truax, P. (1991). Clinical significance: a statistical approach to defining 
meaningful change in psychotherapy research. Journal of consulting and clinical psychology, 
59(1), 12.  
Kompoliti, K., Wilson, B., Stebbins, G., Bernard, B., & Hinson, V. (2014). Immediate vs. delayed 
treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: 
Randomized clinical trial. Parkinsonism & Related Disorders, 20(1), 60-63. doi: 
http://dx.doi.org/10.1016/j.parkreldis.2013.09.018 
LaFrance, W. C., Jr., & Friedman, J. H. (2009). Cognitive behavioral therapy for psychogenic 
movement disorder. Mov Disord, 24(12), 1856-1857. doi: 10.1002/mds.22683 
Lindsay, E. K., & Creswell, J. D. (2017). Mechanisms of mindfulness training: Monitor and 
Acceptance Theory (MAT). Clinical Psychology Review, 51, 48-59. doi: 
http://dx.doi.org/10.1016/j.cpr.2016.10.011 
Ludwig, L., Whitehead, K., Sharpe, M., Reuber, M., & Stone, J. (2015). Differences in illness 
perceptions between patients with non-epileptic seizures and functional limb weakness. 
Journal of Psychosomatic Research, 79(3), 246-249. doi: 10.1016/j.jpsychores.2015.05.010 
ACT IN THE CONTEXT OF FMD 
Macerollo, A., Chen, J.-C., Pareés, I., Kassavetis, P., Kilner, J. M., & Edwards, M. J. (2015). Sensory 
Attenuation Assessed by Sensory Evoked Potentials in Functional Movement Disorders. 
PLoS ONE, 10(6), e0129507.  
McCracken, L. (2011). Mindfulness and acceptance in behavioral medicine: Current theory and 
practice: New Harbinger Publications. 
McCracken, L. M., & Morley, S. (2014). The psychological flexibility model: a basis for integration 
and progress in psychological approaches to chronic pain management. Journal of Pain, 
15(3), 221-234. doi: 10.1016/j.jpain.2013.10.014 
McCracken, L. M., & Vowles, K. E. (2014). Acceptance and commitment therapy and mindfulness 
for chronic pain: model, process, and progress. American Psychologist, 69(2), 178-187. doi: 
10.1037/a0035623 
Morley, S., & Dowzer, C. (2014). Manual for the Leeds Reliable Change Indicator: simple Excel (tm) 
applications for the analysis of individual patient and group data. Leeds, UK: University of 
Leeds.[Links].  
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002). The Work and Social Adjustment 
Scale: a simple measure of impairment in functioning. The British Journal of Psychiatry, 
180(5), 461-464.  
Nielsen, G., Buszewicz, M., Stevenson, F., Hunter, R., Holt, K., Dudziec, M., . . . Edwards, M. 
(2016). Randomised feasibility study of physiotherapy for patients with functional motor 
symptoms. Journal of Neurology, Neurosurgery & Psychiatry. doi: 10.1136/jnnp-2016-
314408 
Nielsen, G., Stone, J., Matthews, A., Brown, M., Sparkes, C., Farmer, R., . . . Edwards, M. (2014). 
Physiotherapy for functional motor disorders: a consensus recommendation. Journal of 
Neurology, Neurosurgery & Psychiatry. doi: 10.1136/jnnp-2014-309255 
Rampello, L., Raffaele, R., Nicoletti, G., Le Pira, F., Malaguarnera, M., & Drago, F. (1996). 
Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different 
hyperprolactinemic potency. Neuropsychobiology, 33(4), 186-188. doi: 10.1159/000119275 
Ricciardi, L., & Edwards, M. J. (2014). Treatment of Functional (Psychogenic) Movement Disorders. 
Neurotherapeutics, 11(1), 201-207. doi: 10.1007/s13311-013-0246-x 
Spitzer, C., Spelsberg, B., Grabe, H.-J., Mundt, B., & Freyberger, H. J. (1999). Dissociative 
experiences and psychopathology in conversion disorders. Journal of Psychosomatic 
Research, 46(3), 291-294. doi: http://dx.doi.org/10.1016/S0022-3999(98)00112-3 
Stone, J. (2009). Functional symptoms in neurology THE BARE ESSENTIALS. Practical neurology, 
9(3), 179-189.  
6WRQH-	(GZDUGV0-+RZ³SV\FKRJHQLF´DUHSV\FKRJHQLFPRYHPHQWGLVRUGHUV"
Movement Disorders, 26(10), 1787-1788. doi: 10.1002/mds.23882 
van der Hoeven, R. M., Broersma, M., Pijnenborg, G. H. M., Koops, E. A., van Laar, T., Stone, J., & 
van Beilen, M. (2015). Functional (psychogenic) movement disorders associated with normal 
scores in psychological questionnaires: A case control study. Journal of Psychosomatic 
Research, 79(3), 190-194. doi: http://dx.doi.org/10.1016/j.jpsychores.2015.06.002 
van der Salm, S. M. A., Erro, R., Cordivari, C., Edwards, M. J., Koelman, J. H. T. M., van den Ende, 
T., . . . Tijssen, M. A. J. (2014). Propriospinal myoclonus: Clinical reappraisal and review of 
literature. Neurology, 83(20), 1862-1870. doi: 10.1212/WNL.0000000000000982 
van Poppelen, D., Saifee, T. A., Schwingenschuh, P., Katschnig, P., Bhatia, K. P., Tijssen, M. A., & 
Edwards, M. J. (2011). Attention to self in psychogenic tremor. Movement Disorders, 26(14), 
2575-2576. doi: 10.1002/mds.23911 
Villatte, M., Hayes, S. C., & Villatte, J. L. (2015). Mastering the clinical conversation: Language as 
intervention: Guilford Publications. 
Voon, V., & Lang, A. E. (2005). Antidepressant treatment outcomes of psychogenic movement 
disorder. The Journal of clinical psychiatry, 66(12), 1529-1534.  
Vowles, K. E., & McCracken, L. M. (2008). Acceptance and values-based action in chronic pain: a 
study of treatment effectiveness and process. Journal of Consulting and Clinical Psychology, 
76(3), 397.  
Vroegop, S., Dijkgraaf, M. G. W., & Vermeulen, M. (2013). Impact of symptoms in patients with 
functional neurological symptoms on activities of daily living and health related quality of 
ACT IN THE CONTEXT OF FMD 
life. Journal of Neurology, Neurosurgery & Psychiatry, 84(6), 707-708. doi: 10.1136/jnnp-
2012-304400 
Wilshire, C. E., & Ward, T. (2016). Psychogenic Explanations of Physical Illness: Time to Examine 
the Evidence. Perspectives on Psychological Science, 11(5), 606-631. doi: 
10.1177/1745691616645540 
Wilson, C. J., Barnes-Holmes, Y., & Barnes-Holmes, D. +RZ([DFWO\'R,³/HW*R´"7KH
Potential of Using ACT to Overcome the Relaxation Paradox. SAGE Open, 4(1).  
Wise, E. A. (2004). Methods for analyzing psychotherapy outcomes: a review of clinical significance, 
reliable change, and recommendations for future directions. Journal of Personality 
Assessment, 82(1), 50-59. doi: 10.1207/s15327752jpa8201_10 
<RQ.1HWWOHWRQ6:DOWHUV./DPDKHZD.	%XV]HZLF]0-XQLRUGRFWRUV¶
experiences of managing patients with medically unexplained symptoms: a qualitative study. 
BMJ open, 5(12). doi: 10.1136/bmjopen-2015-009593 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACT IN THE CONTEXT OF FMD 
Table 1 
Some examples of the relational framing techniques that were used with Claire to facilitate 
psychological flexibility (informed by Villatte et al., 2015) 
Therapist language 
behaviour (µframing¶) 
Clinical example Purpose of the example 
Co-ordination framing  
 
Relations of equivalence 
or similarity between 
stimuli. 
³,WVRXQGVOLNH\RXDUHVD\LQJWKDW\RXUWKRXJKWV
about yourself can change quite often «DOPRVW 
a) like the weather"´ 
 
³« these recurrent stories about being a failure: 
it sounds like they have been with you for a 
while, almost b) like living with an annoying 
flatmate?´ 
To transform the symbolic functions of thoughts to 
include a) transience, b) familiarity.   
 
 
Psychological flexibility (PF) goal: To begin to a) 
draw attention to the distinction between thoughts 
and the person doing the thinking; b) foster a 
willingness to open up to unwanted thoughts.  
 
Hierarchical framing  
 
Relations of inclusion or 
category.  
 
³:KLFKWKLQJVFRXOG\RXGRas a part of 
becoming more present in your life?´ 
To frame behaviours within participant¶VYDOXHV.  
 
PF goal: Increasing the chance of behaviours being 
enacted that are consistent with values. 
Deictic framing  
 
Relations of perspective 
± person, place or time.  
³:KDWZRXOG\RXZDQW\RXUOLIHWRORRNOLNHfive 
years from now, a) ZLWK)0'"´ 
 
³«b) ³,IDQROGHU\RX± you in your seventies ± 
ZDONHGLQWRWKLVURRPZKDWZRXOGVKHVHH"´ 
 
To alter the context of present thoughts and 
feelings, via perspective change, to allow new 
symbolic functions: a) living with FMD, b) self-
compassion.  
 
PF goal: to create a context for increased a) 
engagement; and b) openness to difficult thoughts 
and feelings related to the self.  
Comparative framing 
 
Relations of comparison. 
 
³:KHQ\RXGRWKDWGRHVLWWDNH\RXWRZDUGVor 
DZD\IURP\RXUYDOXHV"´ 
 
To discriminate to the consequences of behaviours. 
 
PF goal: To foster engagement by noticing where 
behaviours areDUHQ¶W consistent with values. 
Conditional framing 
 
Relations of 
consequence or 
dependence. 
 
 ³If I had been though the experiences that you 
describe on my way to diagnosis, then I imagine 
that I might also have those thoughts and 
feelings ± especially when referred to a 
psychologist.´ 
To increase context sensitivity by drawing attention 
to the impact of present context on thoughts and 
feelings. 
 
PF goal: Alongside simple normalising/relationship 
building, to increase awareness of emergent 
thoughts and feelings, and their relation to context.  
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Table 2 
Changes in primary (WSAS) and secondary (CORE-10) outcomes and the process variable (AAQ-II) 
across the period of the intervention. 
 Pre Post Change RCI* CSC* Interpretationd 
WSASa 16/40 0/40 19 6.07 N/Aa Clinical Recovery 
CORE-10b 21/40 2/40 19 5.91 10.84 Clinical Recovery  
AAQ-IIc 31/49* 12/49 19 6.22 22.76 Clinical Recovery  
 
*As recommended by Connell & Barkham (2007), based on Wise (2004), 1.28 SDs were used in calculations as 
opposed to 1.96 SDs.  
a WSAS requires the presence of a condition, thus normative data not applicable.  
b alpha, clinical and non-clinical norms from (Barkham et al., 2013). 
c alpha, clinical and non-clinical norms from (Bond et al., 2011). 
d Based on the guidance of Morley & Dowzer (2014), with criterion b used for WSAS, CORE-10; criterion c for 
AAQ-II. 
 
